Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysisResearch in context

Summary: Background: The outcome of patients with metastatic tumors who discontinued immune checkpoint inhibitors (ICIs) not for progressive disease (PD) has been poorly explored. We performed a meta-analysis of all studies reporting the clinical outcome of patients who discontinued ICIs for reason...

Cijeli opis

Bibliografski detalji

Glavni autori:	Laura Pala, Eleonora Pagan, Isabella Sala, Chiara Oriecuia, Matteo Oliari, Tommaso De Pas, Claudia Specchia, Emilia Cocorocchio, Emma Zattarin, Giovanna Rossi, Chiara Catania, Giovanni Luca Ceresoli, Daniele Laszlo, Jacopo Canzian, Elena Valenzi, Giuseppe Viale, Richard D. Gelber, Alberto Mantovani, Vincenzo Bagnardi, Fabio Conforti
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2024-07-01
Serija:	EClinicalMedicine
Teme:	Immune-checkpoint inhibitors Discontinuation Meta-analysis melanoma NSCLC
Online pristup:	http://www.sciencedirect.com/science/article/pii/S2589537024002608
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!